Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Will be responsible for Woodstock’s manufacturing business as well as leading its supply chain and site operations.
May 11, 2021
By: Charlie Sternberg
Woodstock Sterile Solutions, a blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), has appointed Oliver Vogt as its vice president and general manager – Site Operations. Vogt previously served as general manager for Woodstock and its predecessor, Catalent, for the past three years. “Oliver has done a tremendous job as general manager helping us to stabilize our supply chain and strengthen our site operations, and I look forward to his continued success and partnering with him as a key member of our leadership team,” said Woodstock Sterile Solutions CEO Paul Josephs, whom Vogt will report to in his new role. “Woodstock became an independent company less than two months ago, and we are moving quickly to build our management team with leaders who have the experience and knowledge to help us build our organization into the leader of the blow-fill-seal industry.” In his new role, Vogt is responsible for Woodstock’s manufacturing business as well as leading its supply chain and site operations, including new product development and customer service. Experience Vogt has a diverse background in engineering and leadership roles dating back more than a quarter of a century that will help him to excel in his new position. Before joining Catalent, he served as the general manager of Chicago Operations for Adello Biologics; the vice president of Manufacturing Operations for Merz North America; director of Global Process and Equipment Engineering for Hospira, and he also had stints at TEVA Pharmaceuticals and Abbott Laboratories. “Our customers come to us because we have expertise in BFS development and commercial manufacturing. Right now, there are more than 40 active programs we are involved in with our customers, and over the next three years, we are working to launch more than ten new products. It is a great time to start in my new role as vice president and general manager, and I appreciate the opportunity to build on the success of the organization,” said Vogt.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !